These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Gastroduodenal ulcer pathology and prostaglandins]. Bellanger J; Pointereau-Bellanger A Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323 [No Abstract] [Full Text] [Related]
23. New drugs in gastroenterology. Friedman G Mt Sinai J Med; 1985 Jun; 52(6):484-9. PubMed ID: 3875031 [No Abstract] [Full Text] [Related]
24. [Various problems on refractory peptic ulcers; progress of drug therapy and changes in the concept of peptic ulcer]. Ishimori A; Kawamura T Nihon Rinsho; 1988 Jan; 46(1):146-51. PubMed ID: 3373747 [No Abstract] [Full Text] [Related]
25. Rioprostil: a new prostaglandin for treatment of peptic ulcer disease and NSAID-induced digestive lesions. Proceedings of an international symposium. Wiesbaden, 11-13 June 1987. Scand J Gastroenterol Suppl; 1989; 164():1-253. PubMed ID: 2510250 [No Abstract] [Full Text] [Related]
26. [Peptic ulcer--advances in drug therapy]. Gütz HJ Z Arztl Fortbild (Jena); 1990; 84(16):811-3. PubMed ID: 1977243 [No Abstract] [Full Text] [Related]
27. [The efficacy of the synthetic prostaglandin Cytotec in preventing and treating symptomatic gastropathy]. Normanskiĭ ES; Polunina TE Voen Med Zh; 1996 Feb; 317(2):33-5. PubMed ID: 8677644 [No Abstract] [Full Text] [Related]
28. [Enprostil in the acute treatment of duodenal ulcer: direct comparative study with pirenzepin]. Rohner HG; Beckenbach HP; Daake H; Dammann HG; Hüttemann R; Kalek S; Kühn V; Müller P; Simon B Z Gastroenterol; 1986 May; 24(5):257-61. PubMed ID: 3088860 [TBL] [Abstract][Full Text] [Related]
29. [Is a 1-week treatment enough and safe for the healing of peptic ulcer?]. Pajares JM; Gisbert JP Rev Esp Enferm Dig; 2000 Jan; 92(1):1-4. PubMed ID: 10758728 [No Abstract] [Full Text] [Related]
30. [Controversy and trends in ulcer therapy. 1: Treatment of ulcer manifestation]. Berndt H Z Arztl Fortbild (Jena); 1993 Aug; 87(8):635-42. PubMed ID: 8379202 [No Abstract] [Full Text] [Related]
31. Cytoprotective approach to peptic ulcer therapy: a preliminary dose-finding clinical investigation with triletide. Maggi CA; Ferrari D Pharmatherapeutica; 1985; 4(3 Spec No):141-5. PubMed ID: 4059295 [TBL] [Abstract][Full Text] [Related]
32. Update on peptic ulcer drugs. Aronson B Am J Nurs; 1998 Jan; 98(1):41-6. PubMed ID: 9455332 [No Abstract] [Full Text] [Related]
33. Misoprostol: a prostaglandin for peptic ulcer. DiPalma JR Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901 [TBL] [Abstract][Full Text] [Related]
34. Sucralfate for peptic ulcer--a reappraisal. Med Lett Drugs Ther; 1984 Apr; 26(660):43-4. PubMed ID: 6323938 [No Abstract] [Full Text] [Related]
35. [What is the role of H2 receptor blockers today in ulcer therapy?]. Creutzfeldt W Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690 [No Abstract] [Full Text] [Related]
36. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886 [TBL] [Abstract][Full Text] [Related]
37. Prostaglandins for peptic ulcer: a promise unfulfilled. Hawkey CJ; Walt RP Lancet; 1986 Nov; 2(8515):1084-7. PubMed ID: 2877235 [TBL] [Abstract][Full Text] [Related]
38. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients]. Søndergaard B; Bytzer P Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170 [No Abstract] [Full Text] [Related]
39. Drugs for peptic ulcers. Treat Guidel Med Lett; 2004 Feb; 2(18):9-12. PubMed ID: 15529109 [No Abstract] [Full Text] [Related]